About Genalyte
Genalyte is a company based in San Diego (United States) founded in 2007. Genalyte has raised $141.8 million across 7 funding rounds from investors including Samsara, Verily and Khosla Ventures. The company has 113 employees as of December 31, 2022. Genalyte has completed 1 acquisition, including BaseHealth. Genalyte offers products and services including Merlin. Genalyte operates in a competitive market with competitors including Enumera Molecular, Lyfas, Attomarker, Adsys and Kanichi Research Services, among others.
- Headquarter San Diego, United States
- Employees 113 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genalyte, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$141.8 M (USD)
in 7 rounds
-
Latest Funding Round
$50 M (USD), Series E
Jan 11, 2021
-
Investors
Samsara
& 11 more
-
Employee Count
113
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genalyte
Genalyte offers a comprehensive portfolio of products and services, including Merlin.
Device for rapid automated lab testing with real-time results.
People of Genalyte
Unlock access to complete
Unlock access to complete
Funding Insights of Genalyte
Genalyte has successfully raised a total of $141.8M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $50 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genalyte
Genalyte has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Samsara, Verily and Khosla Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Late-stage life sciences investments are managed via VC and PE.
|
Locked | Locked | Locked | |
|
Seed and early-stage venture capital firm investing in digital solutions for healthcare and energy industries.
|
Locked | Locked | Locked |
Investor details for Genalyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genalyte
Genalyte has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BaseHealth.
Investment portfolio details for Genalyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genomics-driven personalized health risks and recommendations are provided.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Genalyte
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Genalyte
Detailed financials for Genalyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genalyte Comparisons
Peer comparison for Genalyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genalyte
Genalyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enumera Molecular, Lyfas, Attomarker, Adsys and Kanichi Research Services, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Liquid biopsy tools are developed for biomolecule assessment.
|
|
| Locked | Locked | Locked |
Provider of AI-based predictive and preventive digital health test and home remedy
|
|
| Locked | Locked | Locked |
Provider of at-home Covid diagnostic testing services
|
|
| Locked | Locked | Locked |
Provider of AI-based device for rapid blood diagnosis
|
|
| Locked | Locked | Locked |
Develops sensors for medical diagnosis through breath analysis.
|
Detailed competitors of Genalyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genalyte
Complete news archive for Genalyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genalyte
Genalyte was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Genalyte is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Genalyte is a funded company, having raised a total of $141.8M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Genalyte is 113.
Genalyte was founded in 2007 in San Diego, United States, focusing on biotechnology for clinical and life science applications. Next-generation multiplexing technology is developed and commercialized, utilizing silicon chip manufacturing for immunodetection. The Maverick platform employs silicon photonics to measure antibody-antigen binding and nucleic acid hybridization. Instruments support autoimmune disease monitoring, cancer biomarker screening, infectious agent testing, and anti-drug antibody detection, with the first launch occurring in 2012.
Genalyte's top competitors include Lyfas, Attomarker and Adsys.
Genalyte offers Merlin.
Genalyte has made 1 acquisition, including BaseHealth.
Genalyte has 12 investors. Key investors include Samsara, Verily, Khosla Ventures, HHS, and National Cancer Institute.